Issue 01/2008
Release date: 10/21/2008
EDITORIAL
Market Of Possibilities
GENERAL
Ugly Duckling or Beautiful Swan?
Chemical Parks and Their Unexploited Investment Opportunities
EUROPE
A Success Story
How to Foster the Continous Success of the European Chemical Industry
New EU-Countries are Catching Up
The Future of the Chemical and Petrochemical Industry in the 12 New Member States
Efficient Development for Clinical Supply
Ireland: A Desirable Location for -Development and Clinical Production
Research Made In Germany
Europe´s Largest Pharma Market is Regaining a Leading Position in R&D
A Magnet for Foreign Companies
France Offers a Wide Range of Possibilities to Invest in the Chemical Industry
The Source of Economic Success
Germany´s Investment in Biotech is Beginning to pay Off
ASIA
Location, Location, Location
How to Search for a Chemical Site in Asia
Rosy Future
India´s Chemicals Industry on a Growth Path
Winning The Race
Asia to Replace the U.S. and Europe as Pharmaceutical Industry Powerhouse
Access by Train, Plane and Ship
An Industrial Park in China
AMERICA
Time Is Money
Ontario is Fast-tracking Investments in Innovation
The Perfect Fit
Chemical and Advanced Materials -Com-panies have a Home in South Carolina
Where Europe Meets the U.S.
Cincinnati – The Place to be for Chemical and Life Sciences Industries
Brazil: A South American Dragon
Strong and Diversified Economy, Impressive Growth Rates
EUROPE PROFILES
Co-siting Options With BASF
BASF Group Is Open to Co-siting of Third Party Companies at Selected Sites Worlwide
Room To Succeed
Chempark – Europe´s Chemical Park
Chemelot
Relocate your thinking
Excellent Chemical Clusters in the Ruhr Region/Germany
This is ChemSite
Industriepark Gersthofen
Space For Your Success
Chem2Biz
Plug and Play Chemistry
Chemical Site Leuna:
The Positive Trend Continues
Rapid Development in Industriepark Höchst
Large-scale projects characterise the dynamic changes to the site: New Logistics Centre, Substitute Fuel Plant and relocation of Ticona
Industrial Park Behringwerke Marburg
Creating Value for Biotech
